The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

58 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
32
Sulfonamides as Selective NaEBI
Amgen
27
Sulfonamides as Selective NaEBI
Amgen
19
Sulfonamides as Selective NaEBI
Amgen
17
Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of NaV1.7 with Efficacy in Rodent Pain Models.EBI
Xenon Pharmaceuticals
18
Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications.EBI
Merck Research Laboratories
39
Ion channels as therapeutic targets: a drug discovery perspective.EBI
Pfizer
7
Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry.EBI
University of Parma
2
Lactam-stabilized helical analogues of the analgesicµ-conotoxin KIIIA.EBI
Monash University
18
Oxadiazolylindazole sodium channel modulators are neuroprotective toward hippocampal neurones.EBI
University College London
27
Discovery of novel cyclopentane carboxylic acids as potent and selective inhibitors of NaV1.7.EBI
Xenon Pharmaceuticals Inc.
21
2-Aminopyridines as Potent and Selective Nav1.8 Inhibitors Exhibiting Efficacy in a Nonhuman Primate Pain Model.EBI
Merck & Co.
14
Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies.EBI
Sichuan University
27
Identification of Selective Acyl Sulfonamide-Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (NaEBI
Xenon Pharmaceuticals
17
Inhibition of NaEBI
Daiichi Sankyo Co.
49
Discovery of (R)-(3-fluoropyrrolidin-1-yl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)quinolin-2-yl)methanone (ABBV-318) and analogs as small molecule NaEBI
Abbvie
6
5-Oxopyrrolidine-3-carboxamides as NaEBI
Smith, Gambrell & Russell
23
Discovery of Selective Inhibitors of NaEBI
Siteone Therapeutics
6
Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of EBI
Ucb
17
Discovery of Acyl-sulfonamide NaEBI
Genentech
24
Development of ProTx-II Analogues as Highly Selective Peptide Blockers of NaEBI
Merck
7
Functional Characterization of the Nemertide α Family of Peptide Toxins.EBI
Uppsala University
28
Identification of aryl sulfonamides as novel and potent inhibitors of NaEBI
Xenon Pharmaceuticals
2
Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late IEBI
Gilead Sciences
1
The E15R Point Mutation in Scorpion Toxin Cn2 Uncouples Its Depressant and Excitatory Activities on Human NaEBI
The University of Queensland
18
Discovery of Arylsulfonamide NaEBI
Merck
9
Design, Synthesis, and Pharmacological Evaluation of Analogues Derived from the PLEV Tetrapeptide as Protein-Protein Interaction Modulators of Voltage-Gated Sodium Channel 1.6.EBI
TBA
20
Discovery of DS-1971a, a Potent, Selective NaEBI
Daiichi Sankyo
37
Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors.EBI
Amgen
21
Structure- and Ligand-Based Discovery of Chromane Arylsulfonamide NaEBI
Genentech
29
The discovery and optimization of benzimidazoles as selective NaEBI
Pfizer
17
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform NaEBI
Siteone Therapeutics
27
Substituted Indazoles as Nav1.7 Blockers for the Treatment of Pain.EBI
Abbvie
23
Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of N-([1,2,4]Triazolo[4,3- a]pyridin-3-yl)methane-sulfonamides as Potent and Selective hNaEBI
Xenon Pharmaceuticals
4
Peptide therapeutics from venom: Current status and potential.EBI
Peptides International
30
Discovery of morpholine-based aryl sulfonamides as NaEBI
Bristol Myers Squibb
14
Highly potent and selective NaEBI
Pfizer
41
Discovery of Tarantula Venom-Derived NaEBI
Amgen
27
Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaEBI
Icagen
57
QUINOLINES AS MODULATORS OF POLRMTBDB
Pretzel Therapeutics
12
Fluoropyrrolopyridine compound and application thereofBDB
Wuxi Life Fountain Biotech Co.
28
METHOD FOR PRODUCING ARYLAMIDE DERIVATIVEBDB
Chugai Seiyaku Kabushiki Kaisha
8
HETEROCYCLIC COMPOUND, AND INTERMEDIATE THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOFBDB
Wuhan LL Science and Technology Development Co.
122
Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitorsBDB
Valo Health
9
BENZYLAMINE OR BENZYL ALCOHOL DERIVATIVE AND USES THEREOFBDB
Chengdu Hyperway Pharmaceuticals
86
Heterocyclic compounds as RET kinase inhibitorsBDB
Cancer Research Technology
14
7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant IDH1 and IDH2 inhibitorsBDB
Eli Lilly
37
Thienodiazepine derivatives and application thereofBDB
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang)
256
Substituted piperidine compound and use thereofBDB
Takeda Pharmaceutical
173
ASK1 inhibiting agentsBDB
Biogen Ma
440
6-aminopyridin-3-yl thiazoles as modulators of RORγTBDB
Janssen Pharmaceutica
16
Heterocyclic compounds as kinase inhibitorsBDB
Translational Drug Development
38
Morphan and morphinan analogues, and methods of useBDB
Alkermes Pharma Ireland
37
Bicyclic heterocycles as FGFR4 inhibitorsBDB
Incyte
12
Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesisBDB
Pfizer
37
Piperazinyl methanone NAAA inhibitorsBDB
University of California
29
Hexahydrodibenzo[a,g]quinolizine compound, preparation method thereof, pharmaceutical composition and use thereofBDB
Shanghai Institute of Material Medica, Chinese Academy of Sciences
87
Bicyclic heterocycle compounds methods of use thereof for the treatment of herpes virusesBDB
Merck Sharp & Dohme
2
Development of a technique to determine bicyclomycin-rho binding and stoichiometry by isothermal titration calorimetry and mass spectrometry.BDB
University of North Carolina